{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:35:15Z","timestamp":1791758115882,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaip.2025.04.014","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:05:32Z","timestamp":1744729532000},"page":"1440-1448.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dominant-Negative Versus Gain-of-Function STAT3 Defects: A Systematic Review on Epidemiological, Clinical, Immunological, and Molecular Aspects"],"prefix":"10.1016","volume":"13","author":[{"given":"Amirhossein","family":"Hajialigol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Seifi Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Arabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Tamiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christo","family":"Tsilifis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-9170","authenticated-orcid":false,"given":"Mahnaz","family":"Jamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.04.014_bib1","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci"},{"key":"10.1016\/j.jaip.2025.04.014_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2025.04.014_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaip.2025.04.014_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coi.2014.01.015","article-title":"STAT3 is a central regulator of lymphocyte differentiation and function","volume":"28","author":"Kane","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib5","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.014_bib6","first-page":"1","article-title":"Clinicopathological and prognostic role of STAT3\/p-STAT3 in breast cancer patients in China: a meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.04.014_bib7","first-page":"1","article-title":"Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles","volume":"8","author":"Pan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.04.014_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2019.09.022","article-title":"Repurposing of drugs as STAT3 inhibitors for cancer therapy","volume":"68","author":"Thilakasiri","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaip.2025.04.014_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202592","article-title":"Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance","volume":"218","author":"Asano","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2025.04.014_bib10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","article-title":"The Ying and Yang of STAT3 in human disease","volume":"35","author":"Vogel","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.04.014_bib12","series-title":"GeneReviews","article-title":"STAT3 hyper-IgE syndrome","author":"Hsu","year":"1993"},{"key":"10.1016\/j.jaip.2025.04.014_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-042617-053318","article-title":"Host control of fungal infections: lessons from basic studies and human cohorts","volume":"36","author":"Lionakis","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12893-023-02193-2","article-title":"Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome","volume":"23","author":"Mahdaviani","year":"2023","journal-title":"BMC Surg"},{"key":"10.1016\/j.jaip.2025.04.014_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10875-013-9890-5","article-title":"Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome","volume":"33","author":"Freeman","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib17","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jaip.2019.02.041","article-title":"Spectrum of pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency","volume":"7","author":"Dur\u00e9ault","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.014_bib18","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1182\/blood-2013-09-523167","article-title":"A mouse model of HIES reveals pro-and anti-inflammatory functions of STAT3","volume":"123","author":"Steward-Tharp","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.04.014_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2020.00038","article-title":"Aspergillus fumigatus infection in humans with STAT3-deficiency is associated with defective interferon-gamma and Th17 responses","volume":"11","author":"Danion","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET registry","volume":"6","author":"Gernez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.04.014_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome","volume":"122","author":"Renner","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/mi.2011.5","article-title":"New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome","volume":"4","author":"Conti","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib23","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI40891","article-title":"IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice","volume":"120","author":"Cho","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2025.04.014_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1182\/blood-2014-11-610592","article-title":"STAT3: too much may be worse than not enough","volume":"125","author":"Haddad","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.04.014_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2025.04.014_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2025.04.014_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0923-8","article-title":"Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management","volume":"19","author":"Soler-Palac\u00edn","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2025.04.014_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bj.2021.03.003","article-title":"Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype","volume":"44","author":"Faletti","year":"2021","journal-title":"Biomed J"},{"key":"10.1016\/j.jaip.2025.04.014_bib29","article-title":"STAT3 gain-of-function syndrome","volume":"10","author":"Vogel","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2025.04.014_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome\u2014an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.626593","article-title":"Clinical profile of hyper-IgE syndrome in India","volume":"12","author":"Saikia","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2025.04.014_bib34","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"B\u00e9ziat","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2025.04.014_bib35","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2025.04.014_bib36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2025.04.014_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","article-title":"Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency","volume":"5","author":"Chandesris","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jaip.2025.04.014_bib38","first-page":"4167","article-title":"Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome","volume":"130","author":"Dmitrieva","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2025.04.014_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2025.04.014_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2009.07.007","article-title":"Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome","volume":"124","author":"Melia","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib41","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2022.06.007","article-title":"STAT3-confusion-of-function: beyond the loss and gain dualism","volume":"150","author":"Lodi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype-phenotype correlations in STAT3 mutation positive hyper IgE syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2025.04.014_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bmt.1702446","article-title":"Bone marrow transplantation does not correct the hyper IgE syndrome","volume":"25","author":"Gennery","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaip.2025.04.014_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.5993\/AJHB.45.5.2","article-title":"Examining Associations between knowledge and vaccine uptake using the Human Papillomavirus Knowledge Questionnaire (HPV-KQ)","volume":"45","author":"Harrison","year":"2021","journal-title":"Am J Health Behav"},{"key":"10.1016\/j.jaip.2025.04.014_bib45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fped.2020.00575","article-title":"Hematopoietic stem cell transplantation and vasculopathy associated with STAT3-dominant-negative hyper-IgE syndrome","volume":"8","author":"Ponsford","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2025.04.014_bib46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10875-020-00864-w","article-title":"Ruxolitinib controls lymphoproliferation and diabetes in a STAT3-GOF patient","volume":"40","author":"Wegehaupt","year":"2020","journal-title":"J Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825003708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825003708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:28:11Z","timestamp":1752578891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825003708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213219825003708"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.014","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant-Negative Versus Gain-of-Function STAT3 Defects: A Systematic Review on Epidemiological, Clinical, Immunological, and Molecular Aspects","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}